Order Entry
Canada
ContactUsLinkComponent
Human Recombinant Hdm2 (catalytic RING domain) (GST-tag) (from E. coli), GST Tag
Human Recombinant Hdm2 (catalytic RING domain) (GST-tag) (from E. coli), GST Tag
Catalog # 89165-120
Supplier:  Enzo Life Sciences
CAS Number:  
undefined
Human Recombinant Hdm2 (catalytic RING domain) (GST-tag) (from E. coli), GST Tag
Catalog # 89165-120
Supplier:  Enzo Life Sciences
Supplier Number:  UW0200-0025
CAS Number:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products, please provide identification that includes your business name and shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of identification are:

  • • Issued document with your organization's Federal Tax ID Number
  • • Government issued document with your organization's Resale Tax ID Number
  • • Any other Government ID that includes the business name and address

Avantor will not lift restrictions for residential shipping addresses.

Specifications

  • Protein/peptide type:
    Recombinant
  • Source:
    E. coli
  • Species:
    Human
  • Size:
    25 µg
  • Protein/peptide name:
    Hdm2 (catalytic RING domain) (GST-tag)
  • Purity:
    >95% (SDS-PAGE)
  • Formulation:
    Liquid. In TBS, pH 7.5, containing 150mM sodium chloride and 1mM DTT.
  • Purification:
    Glutathione affinity chromatography purified
  • Cat. no.:
    89165-120
  • Supplier No.:
    UW0200-0025

Specifications

About this item

Produced in E. coli.

p53 is a much studied and complex multifunctional protein, which plays a major role in the cellular response to DNA damage and other genomic aberrations. The activation of p53 can lead to either cell cycle arrest and DNA repair, or apoptosis, through its involvement in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for these processes. Activation and regulation of the p53 transcription pathway is controlled by a range of post-translational modifications including acetylation, phosphorylation and ubiquitinylation. In normal cells, p53 is maintained at a low level mainly through Hdm2-mediated ubiquitinylation and subsequent degradation by the proteasome. Hdm2 is a RING domain dependent ubiquitin E3 ligase that utilizes its C-terminal RING domain to promote not only p53 ubiquitinylation, predominantly at the C-terminus of p53, but also to target Hdm2 itself for auto-ubiquitinylation and subsequent degradation. The isolated Hdm2 C-terminal RING domain (residues 418-491) has been shown to be sufficient for both p53 and self-ubiquitinylation activity.